Evolent Health board adds Jill Smith as director; reaffirms Q4 guidance

Evolent Health, Inc.

Cheryl Scott retired from Board on Dec 1, 2025; no disagreement; 21,979 RSUs accelerated.
Jill Smith appointed to Board on Dec 2, 2025; term expiring at 2026 annual meeting; determined independent.
Ms. Smith brings 25+ years of leadership; ex-CEO of DigitalGlobe, Allied Minds; current director at Securitas, Check Point, MDA Space.
Reaffirmed Q4 2025 revenue guidance $462M-$472M and Adj. EBITDA $30M-$40M (unchanged from Nov 6).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.